Clinical Trials · NCT00820885
A Double-Blind Multi-Dose Tolerability and Pharmacokinetic Study of Teduglutide
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Shire
- Enrollment
- 95
- Start date
- Sep 2006
- Locations
- 1 site, United States
- Primary endpoint
- Each dose arm is safe